CIDP - The relevance of recent advances in Schwann cell/axonal neurobiology

Journal of the Peripheral Nervous System

Volumn 16, Issue 1, 2011, Pages 15-23

  Pollard, John D ^a   Armati, Patricia J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CIDP; compact myelin; gangliosides; Na channels; neurofascin; node of Ranvier; paranode; Schwann cell

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; MYELIN;

ARTICLE; DEMYELINATION; HISTOPATHOLOGY; HUMAN; NERVE BLOCK; NERVE FIBER; NERVE FIBER MEMBRANE; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RANVIER NODE; SCHWANN CELL;

ANIMALS; AXONS; HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SCHWANN CELLS;

EID: 79955053079     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00323.x     Document Type: Article

References (71)

1. Arroyo EJ, Scherer S, (2007). The molecular organisation of myelinating Schwann cells. In: The Biology of Schwann Cells., Armati PJ, (Ed). Cambridge University Press, Cambridge, pp 37-54.
2. Asbury AK, Arnason BG, Adams RD, (1969). The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine 48: 173-215.
3. Austin JH, (1958). Recurrent polyneuropathies and their corticosteroid treatment with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81: 157-192.
4. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR, (1989). Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46: 878-884. (Pubitemid 19199372)
5. Bonnaud E, Vital C, Cohere G, Castaing R, Loiseau P, (1974). Recurrent and relapsing polyneuritis. Four cases with ultrastructural studies of the peripheral nerves. Pathol Eur 9: 109-118.
6. Dalakas MC, Engel WK, (1980). Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol 37: 637-640. (Pubitemid 10018490)
7. DeVivo DC, Engel WK, (1970). Remarkable recovery of a steroid-responsive recurrent polyneuropathy. J Neurol Neurosurg Psychiatry 33: 62-69.
8. Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, Soper JR, (1999). Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122: 1383-1390. (Pubitemid 29324858)
9. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV, (1975). Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50: 621-637.
10. Dyck PJ, Pineda A, Swanson C, Low P, Windebank A, Daube J, (1982). The Mayo Clinic experience with plasma exchange in chronic inflammatory- demyelinating polyneuropathy (CIDP). Prog Clin Biol Res 106: 197-204.
11. Eichorst H, (1874). Ueber nervendegeneration und nervenregeneration. Virchows Archiv 59: S1-S25.
12. Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR Jr, Peles E, (2005). Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 47: 215-229. (Pubitemid 41019253)
13. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR, (1995). Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118: 577-595.
14. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK, (1996). Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol 39: 17-28.
15. Guillain G, Barré JA, Strohl A, (1916). Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bulletins et mémoires de la Société des Médecins des Hôpitaux de Paris 40: 1462-1470.
16. Harris W, Newcombe WB, (1929). Recurrent neuritis. Brain 52: 108.
17. Harvey GK, Pollard JD, Schindhelm K, Antony J, (1987). Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J Neurol Sci 81: 215-225. (Pubitemid 17162084)
18. Harvey GK, Schindhelm K, Antony JH, Pollard JD, (1988). Membrane plasma exchange in experimental allergic neuritis: effect on antibody levels and clinical course. J Neurol Sci 88: 207-218. (Pubitemid 19016596)
19. Harvey GK, Pollard JD, Schindhelm K, McLeod JG, (1989a). Experimental allergic neuritis: effect of plasma infusions. Clin Exp Immunol 76: 452-457. (Pubitemid 19172278)
20. Harvey GK, Schindhelm K, Pollard JD, (1989b). IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course. J Neurol Neurosurg Psychiatry 52: 865-870. (Pubitemid 19181345)
21. Hattori N, Misu K, Koike H, Ichimura M, Nagamatsu M, Hirayama M, Sobue G, (2001). Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 184: 57-63. (Pubitemid 32166726)
22. Hinman RC, Magee KR, (1967). Guillain-Barre syndrome with slow progressive onset and persistent elevation of spinal fluid protein. Ann Intern Med 67: 1007-1012.
23. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Cornblath DR, Asbury AK, Griffin JW, McKhann GM, (1999). Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol 45: 168-173. (Pubitemid 29072362)
24. Hoesterman E, (1914). On recurring polyneuritis. Dtsche Z Nervenheilkd 51: 116-123.
25. Hughes RA, Allen D, Makowska A, Gregson NA, (2006a). Pathogenesis of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11: 30-46. (Pubitemid 43344973)
26. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, Van den Bergh P, van Doorn PA, van Schaik IN, (2006b). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 13: 326-332.
27. Hughes RA, (2010). Chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 30: 570-573.
28. Hughes RA, Gorson KC, Cros D, Griffin J, Pollard J, Vallat JM, Maurer SL, Riester K, Davar G, Dawson K, Sandrock A, (2010). Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 74: 651-657.
29. Hyland HH, Russell WR, (1930). Chronic progressive polyneuritic with report of a fatal case. Brain 53: 278-289.
30. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC, (1995). Acute axonal Guillain-Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 38: 218-224.
31. Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meche FG, (1996). Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol 40: 181-187.
32. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10: 220-228.
33. Koski CL, Baumgarten M, Magder LS, Barohn RJ, Goldstein J, Graves M, Gorson K, Hahn AF, Hughes RA, Katz J, Lewis RA, Parry GJ, van DP, Cornblath DR, (2009). Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 277: 1-8.
34. Lampert PW, (1969). Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies. Lab Invest 20: 127-138.
35. Laughlin RS, Dyck PJ, Melton LJ III, Leibson C, Ransom J, Dyck PJ, (2009). Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 73: 39-45.
36. Lonigro A, Devaux JJ, (2009). Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132: 260-273.
37. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK, (1999). Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66: 677-680. (Pubitemid 29186982)
38. Martini R, Groh J, Bartsch U, (2010). Comparative biology of Schwann cell and oligodendrocytes. The Biology of Oligodendrocytes. Cambridge University Press, Cambridge, pp 19-48.
39. Matthews WB, Howell DA, Hughes RD, (1970). Relapsing corticosteroid- dependent polyneuritis. J Neurol Neurosurg Psychiatry 33: 330-337.
40. McCombe PA, Pollard JD, McLeod JG, (1987). Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 110: 1617-1630.
41. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP, (1993). Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33: 333-342. (Pubitemid 23103964)
42. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V, (1999). Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 46: 910-913.
43. Nattrass FJ, (1921). Recurrent hypertrophic neuritis. J Neurol Psychopathol S1-2: 159-165.
44. Plomp JJ, Molenaar PC, O'Hanlon GM, Jacobs BC, Veitch J, Daha MR, van Doorn PA, van der Meche FG, Vincent A, Morgan BP, Willison HJ, (1999). Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 45: 189-199. (Pubitemid 29072365)
45. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, Pevny L, Stewart CL, Xu X, Chiu SY, Shrager P, Furley AJ, Peles E, (2003). Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162: 1149-1160. (Pubitemid 37174196)
46. Pollard JD, (1994). Chronic inflammatory demyelinating polyradiculoneuropathy. Baillieres Clin Neurol 3: 107-127. (Pubitemid 24290889)
47. Pollard JD, (2007). Chronic demyelinating polyneuropathy and Schwann cells. In: The Biology of Schwann Cells., Armati PJ, (Ed). Cambridge University Press, Cambridge, pp 171-184.
48. Prineas JW, (1971). Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol 18: 34-57.
49. Prineas JW, (1972). Acute idiopathic polyneuritis. An electron microscope study. Lab Invest 26: 133-147.
50. Prineas JW, McLeod JG, (1976). Chronic relapsing polyneuritis. J Neurol Sci 27: 427-458.
51. Rios JC, Rubin M, St MM, Downey RT, Einheber S, Rosenbluth J, Levinson SR, Bhat M, Salzer JL, (2003). Paranodal interactions regulate expression of sodium channel subtypes and provide a diffusion barrier for the node of Ranvier. J Neurosci 23: 7001-7011. (Pubitemid 36975866)
52. Roussy G, Cornil L, (1919). Névrite hypertrophique progressive non familiale de l'adulte. Annales de Médecine, Paris 6: 296-305.
53. Said G, (2002). Chronic inflammatory demyelinative polyneuropathy. J Neurol 249: 245-253. (Pubitemid 34212264)
54. Said G, Saida K, Saida T, Asbury AK, (1981). Axonal lesions in acute experimental demyelination: a sequential teased nerve fiber study. Neurology 31: 413-421. (Pubitemid 11151076)
55. Saida T, Saida K, Silberberg DH, Brown MJ, (1978). Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Nature 272: 639-641. (Pubitemid 8305198)
56. Salzer JL, Brophy PJ, Peles E, (2008). Molecular domains of myelinated axons in the peripheral nervous system. Glia 56: 1532-1540.
57. Schafer DP, Custer AW, Shrager P, Rasband MN, (2006). Early events in node of Ranvier formation during myelination and remyelination in the PNS. Neuron Glia Biol 2: 69-79.
58. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, Furukawa K, Furukawa K, Rasband MN, Yuki N, (2007a). Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55: 746-757. (Pubitemid 46663027)
59. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N, (2007b). Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27: 3956-3967. (Pubitemid 46597169)
60. Targowla J, (1894). Polynévrite récidi- vante, envahissement des nerfs crâniens et diplégie faciale. Rev Neurol 2: 465-472.
61. Taylor JM, Pollard JD, (2001). Dominance of autoreactive T cell-mediated delayed-type hypersensitivity or antibody-mediated demyelination results in distinct forms of experimental autoimmune neuritis in the Lewis rat. J Neuropathol Exp Neurol 60: 637-646. (Pubitemid 32523628)
62. Taylor BV, Dyck PJ, Engelstad J, Gruener G, Grant I, Dyck PJ, (2004). Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 63: 129-137. (Pubitemid 38174778)
63. Thomas PK, Lascelles RG, Hallpike JF, Hewer RL, (1969). Recurrent and chronic relapsing Guillain-Barre polyneuritis. Brain 92: 589-606.
64. Willison HJ, (2005). The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst 10: 94-112.
65. Willison HJ, Veitch J, (1994). Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 50: 159-165.
66. Willison HJ, Gregson NA, Hughes RA, (2005). Peripheral nerve antigens. In: Peripheral Neuropathy, 4th Edn., Dyck PJ, Thomas PK, (Eds). Elsevier Saunders, Philadelpia, pp 573-608.
67. Yan WX, Archelos JJ, Hartung HP, Pollard JD, (2001). P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50: 286-292. (Pubitemid 32848730)
68. Yan WX, Mathey E, Yiannikas C, Pollard J, (2010). Antineurofascin antibodies are present in patients with peripheral demyelinating neuropathies and mediate changes in nerve conduction in animals. J Peripher Nerv Syst 15: 288-289.
69. Yuki N, Yoshino H, Sato S, Miyatake T, (1990). Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40: 1900-1902.
70. Yuki N, Sato S, Inuzuka T, Miyatake T, Yoshino H, (1992). Axonal degeneration in the Guillain-Barre syndrome and anti-GM1 ganglioside antibodies. Muscle Nerve 15: 116.
71. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T, (1993). Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43: 414-417. (Pubitemid 23060282)